Tuesday, May 11, 2004 11:19:57 AM
This answer suggests to me (but who knows what is realy going on?):
- That the company doesn't NEED anymore to issue shares to finance its dayly operations.
- That, even if not audited, released financials could ressemble what future audited numbers will say.
- That, AS REPEATEDLY SAID BY THE COMPANY AND THOSE CLOSE TO IT, this could be an extremely undervalued stock (Nobody will ever be able to say they were not told)
- That those close to this NON-REPORTING company are (or have close ones) accumulating at currently very low PPS (Assume you are one of them ... wouldn't you if you KNEW the above?)
- That current lack of credibility caused by apparent to-nice-to-beleive releases fits the interest of those who could change that.
- That accumulation is not necessarely being done from newly issued (3,000,000) shares. About 30,000,000 shares were traded over the last month.
- That the scheme could very well get to its conclusion sooner than later (audited financial, Investrend report, credible testimonies related to the Bingladish operation, normal reporting ...)
If the above is the HYPPOTHESIS that gets confirm, some stands to make millions over the nex 12 to 18 months and no one will be able to say that the company did hide the thruth.
Legal? I do not know. Could the company do this legally considering it's not reporting and it's releasing "fats" (???) on regular basis?
Moral? Probably not but with all the current behaviors in the stock markets, who can expect angelism from companies nowadays?
Logical? Certainly more than the HYPPOTHESIS that this is just a scam used to dump shares in the hands of poor ignorant shareholders.
Not sure enough of the above to add to my position (I like it as it is) but certainly not ready to sell my shares at 1 penny right now.
Look forward to see the end (whatever it end up being) of a very interesting affair...
Patiently,
Roger
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM